Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.
Autorzy:
Chen M; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, China. Wu R; Department of Urology, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, Guangdong, China. Li G; Department of Urology, Guangzhou Red Cross Hospital, The Affiliated Hospital of Medical College of Ji-Nan University, Guangzhou, 510220, Guangdong, China. Liu C; Department of Urology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, Guangdong, China. Tan L; Department of Urology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China. Xiao K; Department of Urology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China. Ye Y; Department of Urology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China. .; Department of Urology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, China. . Qin Z; Department of Urology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, Guangdong, China. .; Department of Urology, Cancer Center, Sun Yat-sen University, Guangzhou, Guangdong, 510060, China. .
CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals.
Autorzy:
Zhang J; Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China.; Department of Otolaryngology-Head and Neck Surgery, The Fifth Affiliated Hospital of the Medical University of Guangzhou, Guangzhou, China. Hu H; Department of Otolaryngology-Head and Neck Surgery, The Fifth Affiliated Hospital of the Medical University of Guangzhou, Guangzhou, China. Zhao Y; Department of Otolaryngology-Head and Neck Surgery, The Fifth Affiliated Hospital of the Medical University of Guangzhou, Guangzhou, China. Zhao Y; Department of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, Henan Province, China.
Pokaż więcej
Źródło:
Cell proliferation [Cell Prolif] 2018 Dec; Vol. 51 (6), pp. e12521. Date of Electronic Publication: 2018 Sep 04.
The circRNA circAGFG1 acts as a sponge of miR-195-5p to promote triple-negative breast cancer progression through regulating CCNE1 expression.
Autorzy:
Yang R; Department of Cell Biology and Genetics, Chongqing Medical University, #1 Yixueyuan Road, Chongqing, 400016, China. Xing L; Department of Endocrine and breast surgery, The First Affiliated Hospital of Chongqing Medical University, #1 Yixueyuan Road, Chongqing, 400016, China. Zheng X; Department of Cell Biology and Genetics, Chongqing Medical University, #1 Yixueyuan Road, Chongqing, 400016, China. Sun Y; Department of Cell Biology and Genetics, Chongqing Medical University, #1 Yixueyuan Road, Chongqing, 400016, China. Wang X; Department of Cell Biology and Genetics, Chongqing Medical University, #1 Yixueyuan Road, Chongqing, 400016, China. Chen J; Department of Cell Biology and Genetics, Chongqing Medical University, #1 Yixueyuan Road, Chongqing, 400016, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2019 Jan 08; Vol. 18 (1), pp. 4. Date of Electronic Publication: 2019 Jan 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer.
Autorzy:
Zhao ZM; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Yost SE; City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. Hutchinson KE; Genentech, Inc., Oncology Biomarker Development, South San Francisco, CA, USA. Li SM; City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. Yuan YC; City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. Noorbakhsh J; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Liu Z; City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. Warden C; City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. Johnson RM; Genentech, Inc., Oncology Biomarker Development, South San Francisco, CA, USA. Wu X; City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. Chuang JH; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Yuan Y; City of Hope Comprehensive Cancer Center and Beckman Research Institute, 1500 E. Duarte Road, Duarte, CA, 91010, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2019 Jan 21; Vol. 19 (1), pp. 96. Date of Electronic Publication: 2019 Jan 21.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies